The most recent trading session ended with Sensus Healthcare, Inc. (SRTS – Free Report) standing at $4.69, reflecting a +1.08% shift from the previouse trading day’s closing. The stock’s change was more than the S&P 500’s daily loss of 0.33%. Meanwhile, the Dow lost 0.37%, and the Nasdaq, a tech-heavy index, lost 0.53%.
Prior to today’s trading, shares of the company had lost 5.11% over the past month. This has lagged the Medical sector’s loss of 3.24% and the S&P 500’s loss of 4.03% in that time.
The upcoming earnings release of Sensus Healthcare, Inc. will be of great interest to investors. The company is predicted to post an EPS of $0.08, indicating a 42.86% decline compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $7.93 million, indicating a 25.61% downward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.33 per share and revenue of $41.82 million. These totals would mark changes of -19.51% and +0.03%, respectively, from last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Sensus Healthcare, Inc. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company’s business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Sensus Healthcare, Inc. is currently a Zacks Rank #4 (Sell).
In terms of valuation, Sensus Healthcare, Inc. is presently being traded at a Forward P/E ratio of 14.28. This represents a discount compared to its industry’s average Forward P/E of 27.74.
The Medical – Instruments industry is part of the Medical sector. With its current Zacks Industry Rank of 71, this industry ranks in the top 29% of all industries, numbering over 250.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Financial Market Newsflash
No financial news published today. Check back later.
